Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blind Controlled Trial of Everolimus in Individuals With PTEN Mutations (RAD001XUS257T)

NCT02991807 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT02991807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02991807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blind Controlled Trial of Everolimus in Individuals With PTEN Mutations (RAD001XUS257T)
Lead sponsor
Boston Children's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
June 12, 2017
Completion date
December 22, 2021
Enrollment
46 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pten gene mutation, pten hamartoma tumor syndrome